Yuting Liu

Title: Yuting Liu: Innovator in Gene Transcription Modulation

Introduction

Yuting Liu is a prominent inventor based in Lexington, MA (US). He has made significant contributions to the field of gene transcription modulation. His innovative work focuses on utilizing antisense oligonucleotides to target regulatory RNAs, which has implications for treating diseases linked to aberrant gene expression.

Latest Patents

Yuting Liu holds a patent for "Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs." This patent describes methods for modulating gene transcription through the use of antisense oligonucleotides (ASOs) that target regulatory RNAs, such as promoter-associated RNAs and enhancer RNAs. These methods are particularly useful for increasing the expression of Carbamoyl-Phosphatase Synthetase 1 (CPS1), which can aid in treating diseases associated with abnormal gene expression. He has 1 patent to his name.

Career Highlights

Yuting Liu is currently associated with Camp4 Therapeutics Corporation, where he continues to advance his research in gene modulation. His work is pivotal in the development of therapeutic strategies that leverage the power of gene regulation.

Collaborations

Some of his notable coworkers include Alfica Sehgal and Bryan J Matthews, who contribute to the innovative environment at Camp4 Therapeutics Corporation.

Conclusion

Yuting Liu's contributions to gene transcription modulation represent a significant advancement in biotechnology. His innovative approaches have the potential to transform therapeutic strategies for various diseases.